ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Hold Sun Pharma and Dr Reddy's; buy Natco on dips among pharma stocks: Mayuresh Joshi
Mayuresh Joshi shares insights on pharma and telecom sectors, focusing on key players like Sun Pharma, Dr Reddy's, Bharti Hexacom, and Exide. The discussion also includes Vodafone's FPO and the potential of Li-Ion battery makers.
Announcement as on 14 April 2024

Dr Reddy's launches migraine management device in Europe
The launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is approved by the US Food and Drug Administration (USFDA), and is CE-mark certified in Europe. Dr Reddy's launched Nerivi
Announcement as on 10 April 2024

Dr Reddys launches migraine management wearable device Nerivio in Germany
Dr. Reddy's Laboratories announced the launch of the drug-free non-invasive migraine management wearable device Nerivio in Germany through its step-down subsidiary betapharm. The launch marks the company's entry into digital therapeutics in Europe. Nerivio
Announcement as on 10 April 2024

Dr Reddys and Bayer partner to market and distribute second brand of Vericiguat in India
Under the terms of this agreement, Bayer has granted non-exclusive rights to Dr. Reddy's under the brand name Gantra.
Announcement as on 05 April 2024

Buy Dr Reddy’s Laboratories; target of Rs 6537: Sharekhan
Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6537 in its research report dated April 01, 2024.
Announcement as on 02 April 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.34
  • 12Day Average: 12.17
  • 20Day Average: 12.03
  • 50Day Average: 13.03
  • 100Day Average: 13.2
  • 150Day Average: 13.46
  • 200Day Average: 13.56

RDY Indicators & signals

Indicator MACD (12,26,9)

12.24, 12.41, -0.29
Indicator MACD is in negative zone

Indicator ADX (14)

22.22, 23.33, 36.67
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Fri Aug 2026 12.27 12.22 to 12.39 -1.21% 0.88 times
13 Thu Aug 2026 12.42 12.37 to 12.51 0.24% 1.1 times
12 Wed Aug 2026 12.39 12.33 to 12.42 -0.48% 0.87 times
11 Tue Aug 2026 12.45 12.42 to 12.58 2.47% 0.93 times
10 Mon Aug 2026 12.15 11.58 to 12.29 -0.57% 0.77 times
07 Fri Aug 2026 12.22 12.12 to 12.26 0.91% 1 times
06 Thu Aug 2026 12.11 12.05 to 12.22 -0.25% 1 times
05 Wed Aug 2026 12.14 12.13 to 12.24 0.33% 0.99 times
04 Tue Aug 2026 12.10 11.97 to 12.21 0.25% 0.8 times
03 Mon Aug 2026 12.07 11.95 to 12.14 1.86% 1.37 times
31 Fri Jul 2026 11.85 11.72 to 11.86 0.17% 1.18 times
30 Thu Jul 2026 11.83 11.75 to 11.87 0.6% 0.82 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top